We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
7951
DELISTED
Altair Engineering Inc
ALTR
$1K ﹤0.01%
18
-50
-74% -$1.69K
TDW.WS
7952
DELISTED
Tidewater Inc.
TDW.WS
$1K ﹤0.01%
2,269
+165
+8% +$112
NTBL
7953
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1K ﹤0.01%
31
-38
-55% -$1.64K
BCDAW
7954
DELISTED
BioCardia, Inc. Warrant
BCDAW
$1K ﹤0.01%
+1,105
New +$1.26K
GENE
7955
DELISTED
Genetic Technologies Ltd.
GENE
$1K ﹤0.01%
65
-638
-91% -$6.23K
SOLO
7956
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$1K ﹤0.01%
300
-1,502
-83% -$2.96K
IMACW
7957
DELISTED
IMAC Holdings, Inc. Warrant
IMACW
$1K ﹤0.01%
3,644
-2,200
-38% -$1.07K
ONCT
7958
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1K ﹤0.01%
21
-60
-74% -$6.21K
MCOMW
7959
DELISTED
micromobility.com Inc. Warrant
MCOMW
$1K ﹤0.01%
+6,000
New +$785
FLZA
7960
DELISTED
Franklin FTSE South Africa
FLZA
$1K ﹤0.01%
+23
New +$602
UFAB
7961
DELISTED
Unique Fabricating, Inc.
UFAB
$1K ﹤0.01%
173
-381
-69% -$1.21K
SVVC
7962
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$1K ﹤0.01%
200
-217
-52% -$1.43K
EMAN
7963
DELISTED
eMagin Corporation
EMAN
$1K ﹤0.01%
3,880
-12,478
-76% -$4.18K
WTT
7964
DELISTED
Wireless Telecom Group, Inc.
WTT
$1K ﹤0.01%
914
-763
-45% -$1.07K
ENTXW
7965
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$1K ﹤0.01%
4,494
+100
+2% +$20
PYPE
7966
DELISTED
ETRACS NYSE Pickens Core Midstream Index ETN due August 20, 2048
PYPE
$1K ﹤0.01%
+40
New +$804
NVNOW
7967
DELISTED
enVVeno Medical Corporation Warrants
NVNOW
$1K ﹤0.01%
7,784
APTX
7968
DELISTED
Aptinyx Inc. Common Stock
APTX
$1K ﹤0.01%
300
-1,959
-87% -$6.75K
CIH
7969
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$1K ﹤0.01%
150
-1,368
-90% -$4.79K
IUSS
7970
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic US Small Company ETF
IUSS
$1K ﹤0.01%
+43
New +$1.03K
FSTX
7971
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1K ﹤0.01%
125
-465
-79% -$5.91K
SDGA
7972
DELISTED
Impact Shares Sustainable Development Goals Global Equity ETF
SDGA
$1K ﹤0.01%
32
-462
-94% -$9.87K
HZN
7973
DELISTED
Horizon Global Corporation
HZN
$1K ﹤0.01%
+244
New +$903
QED
7974
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$1K ﹤0.01%
69
-508
-88% -$11K
AVCT
7975
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$1K ﹤0.01%
8

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.